Kierlin Lara, Littner Michael R
David Geffen School of Medicine at University of California Los Angeles Los Angeles, CA, USA.
Front Psychiatry. 2011 Dec 12;2:71. doi: 10.3389/fpsyt.2011.00071. eCollection 2011.
There exists a varying level of evidence linking the use of antidepressant medication to the parasomnias, ranging from larger, more comprehensive studies in the area of REM sleep behavior disorder to primarily case reports in the NREM parasomnias. As such, practice guidelines are lacking regarding specific direction to the clinician who may be faced with a patient who has developed a parasomnia that appears to be temporally related to use of an antidepressant. In general, knowledge of the mechanisms of action of the medications, particularly with regard to the impact on sleep architecture, can provide some guidance. There is a potential for selective serotonin reuptake inhibitors, tricyclic antidepressants, and serotonin-norepinephrine reuptake inhibitors to suppress REM, as well as the anticholinergic properties of the individual drugs to further disturb normal sleep architecture.
有不同程度的证据表明抗抑郁药物的使用与异态睡眠有关,范围从快速眼动睡眠行为障碍领域规模较大、更全面的研究到主要关于非快速眼动异态睡眠的病例报告。因此,对于可能面对出现似乎与抗抑郁药物使用存在时间关联的异态睡眠患者的临床医生,缺乏具体指导的实践指南。一般来说,了解药物的作用机制,特别是对睡眠结构的影响,可以提供一些指导。选择性5-羟色胺再摄取抑制剂、三环类抗抑郁药和5-羟色胺去甲肾上腺素再摄取抑制剂有可能抑制快速眼动睡眠,以及各药物的抗胆碱能特性会进一步扰乱正常睡眠结构。